Thrombotic thrombocytopenic purpura and sickle cell crisis

Clinical and Applied Thrombosis/Hemostasis

Volumn 16, Issue 2, 2010, Pages 224-227

  Shelat, Suresh G ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

ADAMTS13; Erythrocytapheresis; Plasmapheresis

Indexed keywords

FRESH FROZEN PLASMA; LACTATE DEHYDROGENASE; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ACUTE CHEST SYNDROME; ADOLESCENT; ANEMIA; ARTICLE; CASE REPORT; ENZYME ACTIVITY; FEMALE; FLUID RESUSCITATION; HEADACHE; HEMOLYSIS; HEMOLYTIC ANEMIA; HUMAN; HYPOXIA; IMMUNOBLOTTING; LACTATE DEHYDROGENASE BLOOD LEVEL; PLASMAPHERESIS; PRIORITY JOURNAL; RESPIRATORY DISTRESS; SICKLE CELL CRISIS; TACHYPNEA; THORAX PAIN; THORAX RADIOGRAPHY; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ACUTE CHEST SYNDROME; ADAM PROTEINS; ADOLESCENT; ANEMIA, SICKLE CELL; BLOOD COMPONENT REMOVAL; COOMBS' TEST; DIAGNOSIS, DIFFERENTIAL; ERYTHROCYTES; FEMALE; HEADACHE; HUMANS; L-LACTATE DEHYDROGENASE; PARTIAL THROMBOPLASTIN TIME; PLASMA; PLASMAPHERESIS; PURPURA, THROMBOTIC THROMBOCYTOPENIC;

EID: 77949879998     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/1076029608323804     Document Type: Article

References (25)

1. Ellison AM, Shaw K. Management of vasoocclusive pain events in sickle cell disease. Pediatr Emerg Care. 2007 ; 23: 832-838.
2. Frenette PS Sickle cell vaso-occlusion: multistep and multicellular paradigm. Curr Opin Hematol. 2002 ; 9: 101-106.
3. Terrell DR, Williams LA, Vesely SK, Lammle B., Hovinga JA, George JN The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency. J Thromb Haemost. 2005 ; 3: 1432-1436.
4. Szczepiorkowski ZM, Bandarenko N., Kim HC, et al, the American Society for Apheresis and the Apheresis Applications, Committee of the American Society for Apheresis. Guidelines on the use of therapeutic apheresis in clinical practice: evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher. 2007 ; 22: 106-175.
5. George JN Clinical practice. Thrombotic thrombocytopenic purpura. N Engl J Med. 2006 ; 354: 1927-1935.
6. Baron JM, Baron BW Thrombotic thrombocytopenic purpura and its look-alikes. Clin Adv Hematol Oncol. 2005 ; 3: 868-874.
7. Furlan M., Robles R., Solenthaler M., Lammle B. Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura. Blood. 1998 ; 91: 2839-2846.
8. Sahud MA, Claster S., Liu L., Ero M., Harris K., Furlan M. von Willebrand factor-cleaving protease inhibitor in a patient with human immunodeficiency syndrome-associated thrombotic thrombocytopenic purpura. Br J Haematol. 2002 ; 116: 909-911.
9. Nduka N., Kazem Y., Saleh B. Variation in serum electrolytes and enzyme concentrations in patients with sickle cell disease. J Clin Pathol. 1995 ; 48: 648-651.
10. Jansson L. Relationship of mean platelet volume to platelet count in morphologic evaluation of thrombopoiesis. Scand J Haematol. 1985 ; 35: 363-366.
11. Nelson RB III, Kehl D. Electronically determined platelet indices in thrombocytopenic patients. Cancer. 1981 ; 48: 954-956.
12. Hassell KL, Eckman JR, Lane PA Acute multiorgan failure syndrome: a potentially catastrophic complication of severe sickle cell pain episodes. Am J Med. 1994 ; 96: 155-162.
13. Hiran S. Multiorgan dysfunction syndrome in sickle cell disease. J Assoc Physicians India. 2005 ; 53: 19-22.
14. Chehal A., Taher A., Shamseddine A. Sicklemia with multi-organ failure syndrome and thrombotic thrombocytopenic purpura. Hemoglobin. 2002 ; 26: 345-351.
15. Vichinsky EP, Neumayr LD, Earles AN, et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Engl J Med. 2000 ; 342: 1855-1865.
16. Haut MJ, Cowan DH, Harris JW Platelet function and survival in sickle cell disease. J Lab Clin Med. 1973 ; 82: 44-53.
17. Ballas SK The sickle cell painful crisis in adults: phases and objective signs. Hemoglobin. 1995 ; 19: 323-333.
18. William BM, Corazza GR Hyposplenism: a comprehensive review. Part I: basic concepts and causes. Hematology. 2007 ; 12: 1-13.
19. Mohandas N., Evans E. Adherence of sickle erythrocytes to vascular endothelial cells: requirement for both cell membrane changes and plasma factors. Blood. 1984 ; 64: 282-287.
20. Ballas SK, Larner J., Smith ED, Surrey S., Schwartz E., Rappaport EF Rheologic predictors of the severity of the painful sickle cell crisis. Blood. 1988 ; 72: 1216-1223.
21. Ayache S., J.H. H., Hall N., Kent T., Ballas SK Plasma exchange may benefit acute chest syndrome in sickle cell disease. J Clin Apheresis. 2007 ; 22: 82-83.
22. Kavakli K., Canciani MT, Mannucci PM Plasma levels of the von Willebrand factor-cleaving protease in physiological and pathological conditions in children. Pediatr Hematol Oncol. 2002 ; 19: 467-473.
23. Schnog JJ, Hovinga JA, Krieg S., et al. ADAMTS13 activity in sickle cell disease. Am J Hematol. 2006 ; 81: 492-498.
24. Sucker C., Farokhzad F., Kurschat C., et al. The homozygous Leu variant of the Factor XIII Val34Leu polymorphism as a risk factor for the manifestation of thrombotic microangiopathies. Clin Appl Thromb Hemost.
25. Perkins S. Disorders of hemoglobin synthesis. In: Kjeldsberg CR, ed. Practical Diagnosis of Hematologic Disorders. 4 th ed. Chicago, Ill: ASCP Press ; 2006 :